Bionomics closer to clinical tests
1st Nov 2005, 06:41 GMT
Gene developer Bionomics Ltd is closer to clinically testing an anti-cancer treatment with a drug candidate to be chosen by March.It comes as the South Australian biotech was granted a New Zealand patent for a compound to potentially be used in treating tumours, such as those formed in breast, lung and colon cancer patients.
Bionomics closer to clinical tests related news:
- Bionomics Licenses 2 Epilepsy Diagnostics to Lab Corp of America — Pharmaceuticals News from StratCenter.com
- Translating biomedical research into clinical uses — Business Times Online - Top Stories
- Ministry wants proof that anticancer drugs prolong life — Japan Today: National Headlines
- New studies: Given's PillCamSB outdoes other tests — Israeli stocks on Wall Street |
- Norvartis seeks closer ties with Israel’s R&D community — News
- Beckman Coulter and Consorta Sign Multiple Pricing Agreements for Clinical Lab Systems and Tests — PR Newswire: All Releases
- Bionomics Granted Patent for Anti-Cancer CompoundsASX Announcement — mysan.de
- Clinical Practice Guidelines and Healthcare Decisions: Credibility Gaps and Unfulfilled Promises? — Medscape PublicHealth Headlines
- Citizen tests for OAPs are 'horrendous' — Gravesend Reporter
- Citizenship tests 'unfair' to elderly — Dartford Times